Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02390245 · ClinicalTrials.gov registry record · NA

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

A NA study, sponsored by Wills Eye.

Completed
Registry status
NA
Development phase
906
Enrollment target

NCT02390245 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 906 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02390245, a NA study, has completed, sponsored by Wills Eye.

COMPLETED
Registry status
NA
Development phase
906 participants
Enrollment target

Study Summary

The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect, treat, and manage high-risk patients with previously undiagnosed glaucoma and other eye diseases. Research shows that subject failure to attend follow-up eye care appointments diminishes any previous benefits of community screenings for glaucoma. Greater adherence to follow-up visits can reduce glaucomatous blindness.

Interventions

  • OTHER Usual Care
  • OTHER Enhanced Intervention
  • OTHER Free Eye Screenings

Trial Details

FieldValue
Enrollment Target 906 participants
Start Date 2014-09
Est. Completion 2020-08
Phase NA

Sponsor

Wills Eye

59 total trials

What the Registry Record Tells You About NCT02390245

The ClinicalTrials.gov registry entry for NCT02390245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 906 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.

NCT02390245 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02390245 about?

NCT02390245 is a clinical study titled "Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study". The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect...

What is the current status of trial NCT02390245?

This trial is currently completed. It is a NA study. The enrollment target is 906 participants. The study started on 2014-09. Estimated completion is 2020-08.

What interventions are being tested in trial NCT02390245?

The interventions under investigation include: Usual Care (OTHER), Enhanced Intervention (OTHER), Free Eye Screenings (OTHER).

Who is sponsoring clinical trial NCT02390245?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.